All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
• Kempharm Inc., of North Liberty, Iowa, disclosed results from a second pivotal clinical study of KP201 (benzhydrocodone hydrochloride and acetaminophen) in preparation for a new drug application, which the company anticipates filing in the second quarter of 2014.